Performance analysis of CASI Pharmaceuticals (CASI)
Annual Return
Over the past 3 years, CASI has had an average annual return of -56.35%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, CASI has had an average annual return of -57.18%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, CASI has had an average annual return of -32.65%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Nov 1, 1999, CASI has had an average annual return of -29.26%, underperforming the benchmark SPY, which returned +8.56% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.67% | -72.73% | -62.07% | +314.29% | -78.12% | -73.33% | -4.76% | -22.70% | +23.48% | +180.85% | +20.51% | -27.78% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -20.59% | +21.43% | +43.59% | -81.07% | -42.30% | +395.83% | -86.57% | -24.08% | -18.57% | -40.12% | -2.36% | +286.20% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -89.83% | -51.01% | -32.69% | +14.52% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +33.33% | -75.00% | +0% | +0% | +0% | +0% | -66.67% | ||||||
| 2025 | -9.09% | -10.00% | +0% | -11.11% | +0% | -37.50% | +0% | +80% | -22.22% | -14.29% | -33.33% | -25.00% | -72.73% |
| 2024 | -3.45% | -17.86% | -34.78% | -33.33% | +60% | +37.50% | +31.82% | -6.90% | -7.41% | +0% | -40.00% | -26.67% | -62.07% |
| 2023 | +14.29% | +0% | +12.50% | +33.33% | -8.33% | -9.09% | +0% | -10.00% | +11.11% | +60% | +43.75% | +26.09% | +314.29% |
| 2022 | -15.63% | +25.93% | -2.94% | -48.48% | -17.65% | -14.29% | -16.67% | +50% | -26.67% | -27.27% | +0% | -12.50% | -78.13% |
| 2021 | +13.33% | -26.47% | -3.00% | -24.74% | -10.96% | -3.08% | -25.40% | +38.30% | -26.15% | -8.33% | -18.18% | -11.11% | -73.33% |
| 2020 | -7.94% | -37.93% | +15.28% | -8.43% | +40.79% | -4.67% | -23.53% | -11.54% | -10.14% | +53.23% | +6.32% | +18.81% | -4.76% |
| 2019 | -13.50% | -5.67% | -12.03% | +12.82% | -2.27% | +0.78% | -2.31% | +3.94% | +3.03% | -2.21% | +0.75% | -5.97% | -22.70% |
| 2018 | +28.03% | -16.57% | +19.86% | +60.36% | -7.38% | +33.07% | -11.08% | -5.05% | -32.62% | -30.00% | +32.33% | -7.39% | +23.48% |
| 2017 | +23.40% | +0% | -0% | -17.24% | -14.58% | +4.88% | -4.65% | -4.88% | +84.62% | +18.06% | +47.06% | +5.60% | +180.85% |
Drawdown analysis of CASI Pharmaceuticals (CASI)
The maximum drawdown for the CASI was -100.00%, occurring on Feb 25, 2026. This drawdown has not yet recovered.
The current CASI drawdown is -100.00%.
Since Nov 1, 1999 CASI has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Feb 29, 2000 | 6536 | Feb 25, 2026 | Ongoing | Ongoing | Ongoing |
| -31.07% | Jan 20, 2000 | 7 | Jan 31, 2000 | 12 | Feb 16, 2000 | 19 |
| -19.12% | Dec 9, 1999 | 9 | Dec 22, 1999 | 12 | Jan 10, 2000 | 21 |
| -7.93% | Nov 18, 1999 | 11 | Dec 6, 1999 | 3 | Dec 9, 1999 | 14 |
| -5.91% | Nov 3, 1999 | 6 | Nov 11, 1999 | 5 | Nov 18, 1999 | 11 |
| -2.85% | Feb 22, 2000 | 1 | Feb 23, 2000 | 1 | Feb 24, 2000 | 2 |
| -2.43% | Jan 11, 2000 | 2 | Jan 13, 2000 | 1 | Jan 14, 2000 | 3 |